Related references
Note: Only part of the references are listed.Anti-viral agents: potential utility in exacerbations of asthma
Jaideep Dhariwal et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Efficacy of a Carrageenan nasal spray in patients with common cold: a randomized controlled trial
Martin Ludwig et al.
RESPIRATORY RESEARCH (2013)
Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission
Peter A. B. Wark et al.
RESPIROLOGY (2013)
Prevention of human enterovirus 71 infection by kappa carrageenan
Ya-Huang Chiu et al.
ANTIVIRAL RESEARCH (2012)
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold
Tamas Fazekas et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Respiratory viral infections in children with asthma: do they matter and can we prevent them?
Hamid Ahanchian et al.
BMC PEDIATRICS (2012)
Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold
Ronald Eccles et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Iota-Carrageenan is a potent inhibitor of rhinovirus infection
Andreas Grassauer et al.
VIROLOGY JOURNAL (2008)
Carrageenan is a potent inhibitor of papillomavirus infection
Christopher B. Buck et al.
PLOS PATHOGENS (2006)
The economic burden of non-influenza-related viral respiratory tract infection in the United States
AM Fendrick et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Respiratory illness caused by picornavirus infection: A review of clinical outcomes
AS Monto et al.
CLINICAL THERAPEUTICS (2001)
Epidemiology and prevention of pediatric viral respiratory infections in health-care institutions
DA Goldmann
EMERGING INFECTIOUS DISEASES (2001)
Share Paper
